MOHW's inconsistent drug related policy triggers the mounting discontent

Pharmaceutical industry sources say that the inconsistent drug-related policy of the Ministry of Health and Welfare (MOHW) has rekindled a severe opposition from the domestic pharmaceutical industry, over the MOHW's posture to acknowledge the original insurance price on some of import-switched products of foreign invested pharmaceutical firms from their local product.

Despite the fact that ...